|
Press Releases |
|
 |
|
Friday, March 28, 2025 |
|
Analogue FY2024 Revenue Rose to HK$6,450 Million, Adjusted Profit Attributable to Owners of the Company Increased to HK$206 Million |
Analogue Holdings Limited ('Analogue' or the 'Company', together with its subsidiaries, the 'Group') (stock code: 1977), a leading provider of electrical and mechanical ('E&M') engineering solutions, and information and communications technology services for smart cities, today announced its annual results for the year ended 31 December 2024 (the 'Year' or 'FY2024'). more info >> |
|
安樂工程2024年收益升至64.50億港元 經調整本公司擁有人應佔溢利增至2.06億港元 |
領先的機電工程與智慧城市的資訊及通訊科技服務供應商安樂工程集團有限公司(「安樂工程」或「公司」,連同附屬公司統稱(「集團」))(股份代號:1977),今天宣佈截至2024年12月31日止年度(「年內」或「2024財政年度」)的全年業績。 more info >> |
|
安乐工程2024年收益升至64.50亿港元 经调整本公司拥有人应占溢利增至2.06亿港元 |
领先的机电工程与智慧城市的资讯及通讯科技服务供应商安乐工程集团有限公司(「安乐工程」或「公司」,连同附属公司统称(「集团」))(股份代号:1977),今天宣布截至2024年12月31日止年度(「年内」或「2024财政年度」)的全年业绩。 more info >> |
|
Monday, August 26, 2024 |
|
Analogue Records Profit Attributable to the Owners of the Company of HK$82.4 Million for First Half of 2024 |
Analogue Holdings Limited ('Analogue' or the 'Company', together with its subsidiaries, the 'Group') (stock code: 1977), a leading electrical and mechanical ('E&M') engineering and technology service provider in Hong Kong, today announced its interim results for the six months ended 30 June 2024 (the 'Period'), with revenue growth and steady performance despite navigating through various challenges. more info >> |
|
安乐工程2024年上半年本公司拥有人应占溢利为8,240万港元 |
香港领先的机电工程及技术服务供应商之一安乐工程集团有限公司(「安乐工程」或「公司」,连同附属公司统称(「集团」)(股份代号:1977),今天公布截至2024年6月30日止六个月(「回顾期内」)的中期业绩。集团收益录得增长,业务表现稳健,在应对挑战中前航。 more info >> |
|
安樂工程2024年上半年本公司擁有人應佔溢利為8,240萬港元 |
香港領先的機電工程及技術服務供應商之一安樂工程集團有限公司(「安樂工程」或「公司」,連同附屬公司統稱(「集團」)(股份代號:1977),今天公佈截至2024年6月30日止六個月(「回顧期內」)的中期業績。集團收益錄得增長,業務表現穩健,在應對挑戰中前航。 more info >> |
|
Monday, March 25, 2024 |
|
安乐工程2023年财政年度纯利达2.515亿港元 |
香港领先的机电工程及技术服务供应商之一安乐工程集团有限公司(「安乐工程」或「公司」,连同附属公司统称(「集团」)(股份代号:1977),今天宣布截至2023年12月31日止年度(「年内」或「2023年财政年度」)的全年业绩。 more info >> |
|
安樂工程2023年財政年度純利達2.515億港元 |
香港領先的機電工程及技術服務供應商之一安樂工程集團有限公司(「安樂工程」或「公司」,連同附屬公司統稱(「集團」)(股份代號:1977),今天宣佈截至2023年12月31日止年度(「年內」或「2023年財政年度」)的全年業績。 more info >> |
|
Analogue Records Net Profit of HK$251.5 Million in FY2023 |
Analogue Holdings Limited ("Analogue" or the "Company", together with its subsidiaries, the "Group") (stock code: 1977), a leading electrical and mechanical ("E&M") engineering and technology service provider in Hong Kong, today announced its annual results for the year ended 31 December 2023 ("the Year" or "FY2023") more info >> |
|
Wednesday, October 18, 2023 |
|
Anlev积极扩张全球业务 迈向发展新里程 |
香港领先的机电工程服务供应商之一安乐工程集团有限公司(「安乐工程」或「公司」,连同附属公司统称「集团」)(股份代号:1977)欣然宣布,集团旗下升降机、自动梯及自动人行道国际品牌Anlev Elevator Group(「Anlev」)收购两间位于英国的升降机公司,贯彻集团「迈向国际」的发展策略,见证另一发展新里程。 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
UNFPA and NEC Collaborate to Build Beneficiary Information Management and e-Voucher System
Aug 18, 2025 14:38 JST
|
|
|
Shoucheng Portfolio Wins 37 Medals at Humanoid Robot Games
Aug 18, 2025 10:35 HKT/SGT
|
|
|
The Business Show Asia 2025 Set to Inspire, Connect, and Transform Businesses
Aug 18, 2025 10:30 HKT/SGT
|
|
|
勇奪12金14銀11銅 首程控股多家被投企業閃耀世界人形機器人運動會
Aug 18, 2025 10:23 HKT/SGT
|
|
|
Anime Tokyo Station Surpasses 200,000 Visitors
Aug 18, 2025 11:00 JST
|
|
|
斩获12金14银11铜 摘得大满贯!首程控股多家被投企业闪耀世界人形机器人运动会
Aug 18, 2025 09:57 HKT/SGT
|
|
|
Eisai Launches In-House Developed Anti-Insomnia Drug DAYVIGO(R) (Lemborexant) in China
Aug 18, 2025 9:11 JST
|
|
|
RAK ICC Strengthens Foundations Regime with 2025 Legislative Enhancements
Aug 16, 2025 15:27 HKT/SGT
|
|
|
WL Delicious Announced 2025 Interim Results
Aug 16, 2025 15:25 HKT/SGT
|
|
|
MMG Announces 2025 Interim Results, Profit, Earnings and Cash up on Strong Copper Growth
Aug 16, 2025 14:55 HKT/SGT
|
|
|
Formerra Becomes North American Distributor for Syensqo PVDF
Aug 16, 2025 14:55 HKT/SGT
|
|
|
Cryofocus Medtech Achieves Record Interim Results with 162% Revenue Surge Driven by Respiratory Intervention Products
Aug 16, 2025 14:54 HKT/SGT
|
|
|
How Do AI Workflow Automations Work?
Aug 16, 2025 00:00 HKT/SGT
|
|
|
Everest Medicines' New Drug Application for Etrasimod Accepted in Taiwan, Marking Another Milestone in Asia Market Access
Aug 15, 2025 23:18 HKT/SGT
|
|
|
Etrasimod Receives Strong Recommendation in the ACG Clinical Guideline Update: Ulcerative Colitis in Adults for Induction and Maintenance Phase of Moderately to Severely Active UC
Aug 15, 2025 20:15 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|